Aker BioMarine ASA (OSL:AKBM)

Norway flag Norway · Delayed Price · Currency is NOK
53.70
+0.50 (0.94%)
Apr 24, 2025, 4:25 PM CET
-26.94%
Market Cap 4.67B
Revenue (ttm) 2.26B
Net Income (ttm) 2.05B
Shares Out 87.70M
EPS (ttm) 23.36
PE Ratio 2.28
Forward PE 49.30
Dividend n/a
Ex-Dividend Date n/a
Volume 5,303
Average Volume 32,877
Open 54.50
Previous Close 53.20
Day's Range 52.30 - 54.50
52-Week Range 42.30 - 109.80
Beta 0.77
RSI 45.87
Earnings Date Mar 31, 2025

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ... [Read more]

Industry Packaged Foods
Founded 2006
Employees 249
Stock Exchange Oslo Børs
Ticker Symbol AKBM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

What To Expect From Aker BioMarine ASA (OSL:AKBM) Q4 2024 Earnings

What To Expect From Aker BioMarine ASA (OSL:AKBM) Q4 2024 Earnings

2 months ago - GuruFocus